Turnstone Biologics Corp. (TSBX) Misses Q2 EPS by 455c
Tweet
Share
E-mailGet Alerts TSBX Hot Sheet
Join SI Premium – FREE
Turnstone Biologics Corp. (NASDAQ: TSBX) reported Q2 EPS of ($7.56), $4.55 worse than the analyst estimate of ($3.01).
For earnings history and earnings-related data on Turnstone Biologics Corp. (TSBX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- Definitive Healthcare names Clay Ritchey as new CEO
- PG&E launches strategic review, defers $2B in 2027 capital spending
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
